Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia

The evaluation of minimal residual disease (MRD) in acute leukemia (AL) is currently recognized as a potential critical tool to assess the response and relapse rate of treatments. The present study investigated serum peptides from patients with AL to identify biomarkers that would be useful in provi...

Descripción completa

Detalles Bibliográficos
Autores principales: SONG, WEI, WANG, NA, LI, WEI, WANG, GUANJUN, HU, JIFAN, HE, KUN, LI, YAN, MENG, YING, CHEN, NAIFEI, WANG, SHAOXIN, HU, LINGYUN, XU, BIN, WANG, JIE, LI, AILING, CUI, JIUWEI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813581/
https://www.ncbi.nlm.nih.gov/pubmed/24179540
http://dx.doi.org/10.3892/ol.2013.1574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813581/
https://www.ncbi.nlm.nih.gov/pubmed/24179540
http://dx.doi.org/10.3892/ol.2013.1574

Ejemplares similares